Mitigating Diabetes through Non-Invasive Management with Dental Air Force

It’s not just what goes into your patients’ mouth (like food and metformin) that helps control their blood sugar levels. It’s also about what’s going on with their mouth itself. The tissue surrounding their teeth has a surface area of approximately 9 square inches that is inaccessible to debridement by a toothbrush, floss and other conventional means. It is a palm size portal of entry into the body allowing bacterial pathogens to enter the bloodstream. The periodontal disease is a weeping wound. The body recognizes these organisms as infection with a vast array of associations to other systemic diseases such as diabetes, cardiovascular disease, stroke, Alzheimer’s disease, COPD, chronic kidney disease, macular degeneration, impotence, children with low birth weight, peripheral artery disease, pancreatic cancer, lung cancer, colon cancer, esophageal cancer, and breast cancer. Hidden from physicians and other medical providers with little thought as to the consequences of not addressing this comorbidity, it is arguably the most costly disease in the world.


Introduction
It's not just what goes into your patients' mouth (like food and metformin) that helps control their blood sugar levels. It's also about what's going on with their mouth itself. The tissue surrounding their teeth has a surface area of approximately 9 square inches that is inaccessible to debridement by a toothbrush, floss and other conventional means. It is a palm size portal of entry into the body allowing bacterial pathogens to enter the bloodstream. The periodontal disease is a weeping wound. The body recognizes these organisms as infection with a vast array of associations to other systemic diseases such as diabetes, cardiovascular disease, stroke, Alzheimer's disease, COPD, chronic kidney disease, macular degeneration, impotence, children with low birth weight, peripheral artery disease, pancreatic cancer, lung cancer, colon cancer, esophageal cancer, and breast cancer. Hidden from physicians and other medical providers with little thought as to the consequences of not addressing this comorbidity, it is arguably the most costly disease in the world.

Opinion
Health care providers seeking the best quality of health care delivery for their patients are always looking for a solution to unmet needs that will assist them with providing better outcomes and cost savings to their patients. Periodontal disease has an effect on glucose metabolism as measured by HbA1c. Usually membrane-bound insulin receptors identify the presence of insulin in the blood which in turn regulates the blood sugar levels and activates glucose transporters bringing glucose into the cell for their metabolism and enzymatic production. However, in the presence of periodontal disease and chronic inflammation the formation of C reactive protein, cytokines (Interleukin-1, Interleukin-6 and tumor necrosis factor) and other markers of inflammation disrupt the normal function and obstruct the insulin receptors. This impedes cellular glucose uptake. This cascade of events brings about insulin resistance to both diabetics and non-diabetics making glucose control difficult [1]. Complications occur and can be seen in other systemic diseases such as diabetes, cardiovascular disease, stroke, Alzheimer's disease, chronic kidney disease and macular degeneration [2].
Diabetes and periodontal disease have a bi-directional influence upon each other. People with diabetes are at a much higher risk of periodontal disease and people that have periodontal disease are at a higher risk for diabetes and its complications. The prevalence of periodontal disease in the general population is 50% for 35 year old and rises to 70% by age 65 [3]. The numbers are even more severe for those that are diabetic. Periodontal disease involves a heightened inflammatory host response and greater bone resorption, by osteoclastic action.
Periodontal disease is a biofilm disease that includes several pathogens (Pg, Aa, Fn, and Pi) triggering chronic systemic inflammation [4]. Mitigating these pathogens is the objective of periodontal therapy which lowers the host response of inflammation. However, after traditional periodontal therapy, the pathogen titers quickly reestablish themselves in the biofilm. A means to control this biofilm after periodontal therapy is necessary.
Dental Air Force is a device to assist in better outcomes for diabetic and cardiovascular patients. In one published six month study using Dental Air Force as an adjunct to periodontal therapy, a 1.04% reduction in HbA1c was observed in a population of 50 patients in Figure 1. A reduction also occurred in nondiabetics as well [5]. As a review, the British Medical Journal (BMJ) reported a 1% reduction in HbA1c levels gives the following reduction in combined diabetes-related endpoints [6]:   Dental Air Force is a non-invasive home management tool that has shown a reduction of Pg, Aa, Fn, and Pi by 500% over the course of the study, unlike periodontal therapy followed by toothbrush maintenance [7]. It is an FDA approved for marketing medical device that mitigates the pathogens of periodontal disease that initiates a patient's chronic inflammatory host response Figure 2. New medical coding exists for the prescription of this medical device based on medical necessity [8,9]. It is up to the practitioner to utilize these codes to establish third-party payment for the patient.